# A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain

> **NCT05219812** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 80 (actual)

## Conditions studied

- Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
- Peripheral Neuropathic Pain
- Diabetes Mellitus

## Interventions

- **DRUG:** BAY2395840
- **DRUG:** Placebo for BAY2395840

## Key facts

- **NCT ID:** NCT05219812
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-16
- **Primary completion:** 2022-11-07
- **Final completion:** 2022-11-21
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05219812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05219812, "A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05219812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*